LETTER
Reevaluation of Amiodarone
Zia Ahmed, MD, and
Joel M. Goldman, MD
15 November 1995 | Volume 123 Issue 10 | Page 809
TO THE EDITOR:
In his comprehensive review of amiodarone, Dr. Podrid [1] discusses minor thyroid abnormalities, particularly the elevation of thyroid-stimulating hormone (TSH) levels. He does not mention the more common and more problematic elevation in thyroxine levels. Elevation of TSH levels is only transient, and levels gradually return to pretreatment values [2, 3]. In contrast, thyroxine and free thyroxine levels remain elevated [2, 3]. This condition can be confused with hyperthyroidism, which also occurs in a few patients receiving amiodarone. It can be difficult to distinguish between a euthyroid patient receiving amiodarone and an amiodarone-treated patient who has become hyperthyroid [3, 4]. Ultrasensitive TSH assays and measurement of triiodothyronine and free triiodothyronine levels can be useful in this setting [3, 4].
|
Author and Article Information
|
|---|
Brookdale Hospital Medical Center; Brooklyn, NY 11212
1. Podrid PJ. Amiodarone: reevaluation of an old drug. Ann Intern Med. 1995; 122:689-700.
2. Nademanee K, Piwonka RW, Singh BN, Hershman JM. Amiodarone and thyroid function. Prog Cardiovasc Dis. 1989; 31:427-37.
3. Wiersinga WM, Trip MD. Amiodarone and thyroid hormone metabolism. Postgrad Med J. 1986; 62:909-14.
4. Lombardi A, Martino E, Braverman LE. Amiodarone and the thyroid. Thyroid Today. 1990; 13:1-7.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.